FBT
NVAX icon

Founders Bank & Trust’s Novavax NVAX Stock Holding History

Founders Bank & Trust’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$3K Hold
25
– – ﹤0.01% 335
2014
Q3 		$2K Hold
25
– – ﹤0.01% 342
2014
Q2 		$2K Hold
25
– – ﹤0.01% 342
2014
Q1 		$2K Hold
25
– – ﹤0.01% 345
2013
Q4 		$3K Buy
+25
New +$1.77K ﹤0.01% 363

Other funds holding NVAX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Founders Bank & Trust's NVAX Position: Q4 2014 in Review

Founders Bank & Trust held its Novavax (NVAX) position steady in Q4 2014 at 25 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #335.

Founders Bank & Trust first reported a position in NVAX in Q4 2013 and has held it in 5 quarters since. 153 funds tracked by Wall St. Rank hold NVAX as of Q4 2014.

  • Founders Bank & Trust held 25 shares of Novavax worth $3K as of Q4 2014.
  • Founders Bank & Trust left its Novavax share count unchanged in Q4 2014.
  • Novavax made up ﹤0.01% of Founders Bank & Trust's portfolio in Q4 2014, its #335 holding.
  • Founders Bank & Trust first reported a position in Novavax in Q4 2013 and has held it in 5 quarters since.
  • 153 funds tracked by Wall St. Rank held Novavax as of Q4 2014.

Based on Founders Bank & Trust's 13F filing for Q4 2014, filed 9 Feb 2015.